Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 5
Submit an article Journal homepage
94
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Alemtuzumab in Relapsed or Refractory Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia

Steven L. McCune Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Jon P. Gockerman Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Joseph O. Moore Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Carlos M. Decastro Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Adam J. Bass Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Nelson J. Chao Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Gwynn D. Long Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
James J. Vredenburgh Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Cristina Gasparetto Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Donna Adams Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
,
Nancy Payne Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
&
David A. Rizzieri Division of Medical Oncology and Transplantation, Department of Medicine, Duke University Medical Center, Campus Box 3841, Durham, NC 27710, USA
 show all
Pages 1007-1011 | Published online: 01 Jul 2009

  • Kalil, N. and Cheson, B.D. (2000) "Management of chronic lymphocytic leukemia", Drugs and Aging 16, 9-27.
  • Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D. and Schiffer, C.A. (2000) "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia", The New England Journal of Medicine 344, 1166-1168.
  • Keating, M.J., O'Brien, S., Lerner, S., Koller, C. Beran, M., Robertson, L.E., Freireich, E.J., Estey, E. and Kantarjian, H. (1998) "Long-team follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy", Blood 92, 1165-1171.
  • Byrd, J.C. and Raj, K.R. (2000) "What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?", Seminars in Oncology 27, xii-xvi.
  • Dyer, M.J. (1999) "The role of CAMPATH-1H antibodies in the treatment of lymphoid malignancies", Seminars in Oncology 26, S52-S57.
  • Rai, K., Mercier, R.J., Cooper, M.R., Freter, C.B., Brettman, L. and Santabarbara, P. (2000) "Campath-1H is an effective salvage therapy for fludarabine failing CLL patients. Results of a phase II trial", Blood 96(Suppl. 1), 163a.
  • Osterborg, A., Dyer, M.J., Bunjes, D., Pangalis, G.A., Bastion, Y. Catovsky, D. and Mellstedt, H. (1997) "Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia", Journal of Clinical Oncology 15, 1567-1574.
  • Osterborg, A., Fassas, A.S., Anagnostopoulos, A., Dyer, M.J., Catovsky, D. and Mellstedt, H. (1996) "Humanized CD52 monoclonal antibody CAMPATH-1H as first-line treatment in chronic lymphocytic leukaemia", British Journal of Haematology 93, 151-153.
  • Kennedy, B., Rawstron, A.C., Evans, P., English, A., Haynes, A.P., Russell, N.H., Byrne, J., Hale, G., Morgan, G.J. and Hillmen, P. (1999) "CAMPATH-1H therapy in 29 patients with refractory CLL: "true"' complete remission is an attainable goal", Blood 94(Suppl. 1), 603a.
  • Pawson, R., Dyer, M.J. and Barge, R. (1997) "Treatment of T-cell prolymphocytic leukemia with human CD52 antibody", Journal of Clinical Oncology 15, 2667-2672.
  • Dearden, C. (2001) "Campath-1H in T-cell prolymphocytic leukemia", CLL 6, 5-7.
  • Dyer, M.J.S. (2001) "Mechanisms of action of Campath-1H antibodies", CLL 6, 2-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.